Tag: Stimwave

Stimwave launches post-market peripheral neuropathy pain relief randomised controlled trial

In honour of September Pain Awareness Month, Stimwave has announced the launch of a new randomised clinical trial treating painful peripheral neuropathy, known as...

The first wireless spinal cord stimulator system elicits a high response...

A study evaluating different waveforms within a wireless spinal cord stimulator (SCS) device (Stimwave) has found high response rates for patients receiving both high...

Stimwave announces publication of 10 kHz Freedom Stimulator SURF RCT results

Stimwave has announced publication of the results of the first ever randomised, controlled trial (RCT) comparing wireless high-frequency (HF: 10 kHz) spinal cord stimulation...

Stimwave address patent infringement lawsuit brought by Nevro

Stimwave issued a statement today in response to a complaint made by Nevro in Federal Court Delaware District last week alleging Stimwave is infringing...

Nevro files lawsuit for patent infringement against Stimwave

Nevro has announced that it has filed a lawsuit for patent infringement against Stimwave Technologies. The lawsuit, filed in the United States District Court...

Completion of SURF randomised clinical trial of SCS system

Completion of long-term clinical data from the SURF study (Stimwave Technologies) has been announced. The results are now pending publication. The SURF RCT study,...

Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...

Stimwave Technologies has announced that it has received US Food and Drug Administration (FDA) clearance for the WaveCrest Mobile iOS platform patient controllers for...

US FDA clears Stimwave’s full-body MRI-ready wireless peripheral nerve stimulator

Stimwave has received US Food and Drug Administration (FDA) 510(k) clearance for the first wireless, micro-technology neuromodulation device that can enable ongoing full-body MRI...

CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...

Australian Therapeutic Goods Administration approves Freedom spinal cord stimulation system

The Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for the Freedom Spinal Cord Stimulation (SCS) System (Stimwave). The company launched the product...